The DEA's focus on opioid prosecutions has shifted to doctors treating addiction, as seen in Tennessee, where three doctors were convicted for prescribing Suboxone for addiction treatment "outside the usual practice of medicine," raising concerns about the future of opioid addiction treatment and the broader implications for medical practice.